In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions.
My Saved Results
Join Our Mailing List
Home / Clinical Trials / Find Clinical Trials / A Phase 2 Study of Brentuximab Vedotin in Relapsed or Refractory...
I'm a new user and need a user account
Forgot your password?
This is a single-arm, open-label, multicenter, phase 2 clinical trial to evaluate the efficacy and safety of brentuximab vedotin as a single agent in patients with CD30-positive non-Hodgkin lymphoma (NHL).
Winship Cancer Institute of Emory University1365 Clifton Road NEBuilding CAtlanta, GA 30322404-778-5180winshipcancer.emory.edu